Bresch said the drug pricing model in the U.S. has to change, but offers few suggestions as to how.
Latest posts by Market Watch (see all)
- Market Extra: How some ‘Trump trades’ have performed as he nears his 100th day in office - April 27, 2017
- Market Extra: Dow rally from election to Trump’s first 100 days on track for postwar record - April 27, 2017
- Personal Finance Daily: The latest American status symbol and how adding calorie counts makes us healthier - April 27, 2017